Dear Editor, Breakthrough pain (BTP) is defined as a transitory exacerbation of pain experienced by a patient with an otherwise stably maintained analgesia [1] . BTP encompasses several specific categories of pain which can be distinguished because of their unique physiopathology. Pain on movement, also called incident pain (IP), represents a distinct kind of BTP. IP strongly limits physical activity in most cancer patients, portraying a negative impact on their quality of life (QoL) [2] . IP [3, 4] and motor disability (MD) [5, 6] have been reported as common concerns for patients with hematological malignancies (HM), especially for those affected by multiple myeloma (MM) [7] . In order to explore the relationship between IP and MD, we have conducted a 2-year observational study including a consecutive sample of 130 HM patients admitted to our hematological unit from November 2007 to November 2009. Activities of daily living (ADL) of each patient were assessed weekly by Barthel index [8] ; the impact of IP in limiting ADL and motor function was measured as follows: grade 1 (absence of MD), grade 2 (mild functional motor impairment without any impact on ADL), grade 3 (MD with mild to moderate impact on ADL), and grade 4 (MD with severe impairment of ADL). There were 130 patients with a median age of 67 years (41-79 years). Among 130 patients, the HM diagnoses were as follows: 43 (33%) acute leukemias, 43 (33%) Non-Hodgkin's lymphomas, 22 (17%) MM, and 22 (17%) myelodysplastic syndromes/chronic myeloproliferative disorders. Out of 130 patients, 55 (42%) presented impaired ADL and 33 (25%) experienced IP. The relationship between IP and MD, expressed in terms of the effect portrayed by the former in limiting patient's ADL, resulted in grades 3-4 in 14/33 (42%), grade 2 in ten of 33 (30.3%), and grade 1 in nine of 33 (27.3%) patients. In particular, out of 55 patients with impaired ADL, nine presented IP as the only disabling mechanism. Details about patients with severe ADL impairment are reported on Table 1 . As previously reported, HM may be progressively complicating by debilitating deteriorations of the personal status, physical deconditioning, and several forms of MD. Although MD is a frequent complaints of HM patients [5] who may experience at the same time several forms of IP [3, 4, 7] , very few information regarding their origins, frequency, and relationship have been provided so far. In the present study, we have explored the impact of IP as a pathological mechanism of physical disability. Our data showed that a large variety of IP as underlying cause of MD may be observed in this setting. In conclusion, our data provide new insights on a neglected issue in malignant hematology, such as the IP-related MD. Extended data analysis is required to achieve a better understanding about the disablement process and its related risk factors in this setting in order to plan effective programs to treat IP and to identify appropriate targeted rehabilitative approach to prevent disability and, thus far, to provide positive effects on both patient's QoL and caregiver work-load. 
